We’re excited to announce the acceptance of two late-breaking data presentations at the upcoming American Heart Association (AHA) Scientific Sessions 2025, taking place November 7-10 in New Orleans. Learn more here: https://t.co/OR767phik9 @AHAScience #AHA25

September is Leukemia & Lymphoma Awareness Month. In the U.S., 1.6 million people live with or are in remission from blood cancers like leukemia & lymphomas - that’s about 25 football stadiums full of people.

It’s Time to Lead: America Needs to Get Serious About Plastic Recycling "Will the United States fall behind in recycling innovation or lead the world in transforming plastic waste into economic opportunity?"

This month is #SickleCellAwarenessMonth. For people living with #SCD, their red blood cells are crescent-shaped due to a genetic mutation. This shape of blood cell can lead to blockages that cause debilitating pain episodes. Learn more about #SCD at: https://t.co/rcA79BbKv9

Today, we announced our second quarter earnings results. Read more about our recent highlights and outlook: https://t.co/QIUKeP04T0 #CRSP

We're proud to be named on @TIME's Most Influential Companies of 2025 list – a recognition for our work toward bringing genetic medicines to people suffering from serious diseases on a global scale. Congrats to all the #TIME100Companies!

Let’s assume country X plans to take action against country Y for a while. X will start by developing a large range of options for Y to step into depending on its sophistication level— in other words, the larger the scale of action I want to take the longer I stir the pot..

Today, we announced updates across our in vivo cardiovascular programs, which include new data for CTX310 (targeting ANGPTL3) as well as continued progress on CTX320 (targeting the LPA gene) and CTX340 (targeting the AGT gene): https://t.co/PkdarKCqds

On #WorldSickleCellDay, we #ShinetheLightonSickleCell and raise awareness about the impact of #SickleCellDisease. Learn more about #SCD here: https://t.co/tQZ2ctyBxQ

Meet Keturah, an individual living with #TCellLymphoma. From her long journey to diagnosis, to her role as an advocate for the T cell lymphoma community, Keturah's story continues to inspire us. Read her story here: https://t.co/miIJzR7d6Q

Today, we announced a collaboration with Sirius Tx to co-develop SRSD107, a next generation, long-acting Factor XI siRNA for the treatment of thromboembolic disorders. This will expand our cardiovascular portfolio and broaden our therapeutic toolkit. https://t.co/h4aG9TkNeR

May is #LupusAwarenessMonth and today is #WorldLupusDay. This month, the community comes together to raise awareness about #lupus and its impact on many facets of life. Learn more about this awareness month at @LupusOrg's website: https://t.co/1wcz1ZAPcw

Today is #WorldThalassemiaDay. #Thalassemia is a #blooddisorder where the body does not make enough hemoglobin, which carries oxygen to the cells in the body. Today, we raise awareness for this condition. Learn more about it here: https://t.co/yaTFSWMIHg

You can read the feature article on @CrisprSam here:

The #TIME100HEALTH 2025 list features inspiring trailblazers who are reshaping the future of healthcare. Congrats to our CEO & Chairman @CrisprSam on being named to the list, and congrats to all the honorees. Read the full list here: https://t.co/VWVPD6Qv4L

Today, we reported our first quarter earnings results and announced positive top-line data from our Phase 1 clinical trial of CTX310™ targeting ANGPTL3. Read more about our recent highlights and business update: https://t.co/JpBY9khOk6 #CRSP #CRISPRTX

#NationalCancerResearchMonth is an awareness campaign initiated and supported by the @AACR. We are proud to recognize this initiative, which highlights the importance of innovative cancer research. Learn more here: https://t.co/cCYYvWFNIe

March 24th is Lipoprotein(a) Awareness Day, an initiative by the @FamilyHeartFdn. This day aims to raise awareness of elevated Lipoprotein(a), also known as Lp(a), as an under-recognized cause of premature heart disease and stroke. Learn more at: https://t.co/gFDk9QT9Ah #KnowLpa

Today, we announced our fourth quarter and full year earnings results. Read more about our recent highlights and outlook: https://t.co/xj1WKBelsW

We are excited to highlight our strategic priorities and outlook for 2025 as we enter our next phase of growth. Learn more here: https://t.co/KaBggQZOTg #CRISPRTX

We are pleased to share that we will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference. We hope you can join us for the presentation on Tuesday, January 14 at 2:15pm PT in San Francisco: https://t.co/TbZoHZVJeR #CRISPRTX

We are pleased to invite Briggs Morrison, M.D., to join our Board of Directors. His extensive experience in the pharmaceutical industry and expertise in clinical development will be invaluable as we continue advancing our platform and pipeline. Learn more: https://t.co/jYkGrdFUSe